We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Calcium Channel Blockers Less Effective than Diuretics

By HospiMedica staff writers
Posted on 25 Sep 2000
Print article
An meta-analysis of nine studies involving more than 27,000 patients has revealed that calcium channel blockers are less effective than other, less-costly drugs in preventing complications of high blood pressure such as congestive heart failure and heart attacks. The other drugs used by patients in the analysis included diuretics, beta blockers, and angiotensin-converting enzyme (ACE) inhibitors. The meta-analysis was conducted by a team of researchers from Wake Forest University School of Medicine (Winston-Salem, NC, USA), the University of Washington (Seattle, USA), and the Albert Einstein College of Medicine (New York, NY, USA) and reported at a meeting of the European Society of Cardiology in Amsterdam.

Although calcium channel blockers do not harm patients, they are less effective and therefore the users do not enjoy the protection against heart attacks and heart failure that they would receive from other antihypertensive drugs. The researchers found that patients treated with calcium channel blockers had a 27% higher risk of heart attack and a 26% higher risk of heart failure than other patients. They found no difference, however, in the number of deaths from all causes or the risk of stroke. All drugs, including the calcium channel blockers, lowered blood pressure by the same amount. These results show that preventing heart attacks is more complicated than simply lowering blood pressure to a normal level.

According to the team's leader, Dr. Curt D. Furberg of the Wake Forest University School of Medicine, calcium channel blockers cost 12-15 times the cost of a diuretic drug. Dr. Furberg says low-dose diuretics should be considered standard therapy for hypertension and all new classes of drugs should be compared to them.
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Treadmill Test (TMT) System
GEMINI
New
Electric Drill
Orthodrive MBQ-701

Print article

Channels

Surgical Techniques

view channel
Image: Bioresorbable, 3D-printed tracheobronchial splint device (Photo courtesy of Michigan Medicine)

First-Of-Its-Kind Bioresorbable Implant to Help Children with Rare Respiratory Disease

Tracheobronchomalacia is a rare, life-threatening condition in which the cartilage in the trachea or mainstem bronchi develops abnormally, causing the airway to collapse and making breathing difficult for children.... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.